Publication | Closed Access

Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer—Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial

High-risk Prostate Cancer—resultsUrologyRadiation MedicineRadiation TherapyMedicineDocetaxel Versus SurveillanceProstatic DiseaseOncologyRadiation OncologyRadical Radiotherapy